In this episode, VibeCast host Ray Dogum speaks with Dr Richard Johnson, Founder and CSO of Upperton Pharma Solutions, about drug delivery technologies and the challenges pharmaceutical companies face when integrating new drug delivery technologies into their pipeline.

The key moments in this episode are:
00:00:06 - Introduction,
00:00:42 - Richard Johnson's Background and Upperton's Beginnings,
00:03:24 - Interest in Drug Delivery Technologies,
00:04:48 - Services Provided by CDMOs,
00:07:26 - Evolution of Drug Deliver
00:15:24 - Selection of Dosage Form,
00:16:50 - Quick and Defined Development Process,
00:18:59 - Challenges in Drug Delivery Technologies,
00:21:59 - Considerations for Nasal Delivery,
00:24:28 - Upperton's Client Base,
00:28:54 - Conclusion
--------------------------------------------------------------------------------------------
Upperton Pharma Solutions is excited to invite you to our exclusive Seminar & Networking Event in Boston on Monday 11th & Tuesday 12th September 2023
­Clinical Development of Spray Dried Oral and Nasal Dosage Forms:
Presented by Dr Ian Lafferty, Chief Technical Officer and Dr Richard Johnson, Founder & Chief Scientific Officer, Upperton Pharma Solutions, Nottingham UK.

Monday 11th September
Location: Mosaic Suite at CIC Cambridge, 1 Broadway, Cambridge, MA 02142

Tuesday 12th September
Location: The Embassy Suites Waltham, 550 Winter Street Waltham, MA 02451

Agenda
10.00 am Coffee and Registration
10.30 am Applications of Spray Drying: Bioavailability Enhancement and Particle Engineering
10.45 am Spray Dried Oral Dosage Forms (developing phase -appropriate clinical dosage forms) Phase I strategies; Powder in Bottle versus Tablet, Phase II and beyond; Optimisation and scale up
12.00 pm Lunch and networking
1.00 pm Nasal Dosage Forms
Why is there a rapidly increasing interest in nasal delivery? ; overview of delivery route and device selection
UpperNoseTM Platform; Rapid development and selection of optimised prototypes for clinical evaluation
2.30 pm Drinks and networking
4.00 pm Close
--------------------------------------------------------------------------------------------

Guest Bio:
Dr Richard Johnson graduated from York University, UK (1982) and completed his PhD at Warwick University, UK (1986). His industrial career started at Delta Biotechnology in Nottingham, UK where he worked as a Senior Scientist working on a number of recombinant human proteins.

In 1994 he jointly founded Andaris Ltd, a drug delivery company that utilised spray drying to develop novel diagnostics and and drug delivery products. Andaris was acquired in 1998 and after a successful handover he left to found Upperton Pharma Solutions in 1999.

Initially Upperton focussed on developing its own, novel drug delivery products but since around 2008 the company switched its focus to become a fully focussed CDMO.

In late 2021, as the company expanded he brought in a new CEO to direct our continued growth and my role switched to that of Chief Scientific Officer

Guest Links:
Linkedin:   / richard-johnson-1628111  

About VibeCast
VibeCast is our weekly informational podcast and content series exploring the hottest topics in drug development and Web3 with some of the dynamic people that make up the Vibe community. VibeCast is a collection of long-form and short-form video content intended to help our community learn about the current opportunities and challenges in biotech fundraising and community engagement innovation.

Guests will include biotech founders, regulatory experts, drug development executives, blockchain technologists, web3 community builders, patient community advocates, and many other Vibe Bio community members seeking to accelerate the development of breakthrough treatments.

Follow Vibe Bio's Socials:
  / vibebio  
  / vibe-bio  
  / vibebiotechnology  
  / vibebio  
  / vibebiotechnology  

Disclaimer: VibeCast is intended to be used for educational and entertainment purposes, and no information or opinions shared constitute advice or services. While guests are invited to listen, listeners acknowledge they are not being provided professional advice from the podcast or the guests. The podcast is for private non-commercial use and the statements of our guests reflect their personal views only and do not necessarily reflect the views or positions of any agency, organization, or company that they work for or are affiliated with.